FDA and FTC Compliance Cost for Supplement Brands in 2026

Here is the part most supplement founders underprice: staying legal does not come with an FDA invoice. There is no government fee to review your label, to file a structure/function claim, or to notify FDA of a new ingredient. The cost is real anyway. It shows up as consultant hours, lab fees, an attorney reading your ad copy, and in the worst case a clinical study that costs more than your first year of inventory.

So let me give you the operator version: what FDA and FTC actually require of a supplement brand, what each piece costs in 2026 dollars, and how to fold it into your margins so a compliance bill never lands as a surprise.

The three jobs FDA and FTC split between them

Compliance for a supplement brand is really two regulators with two different jobs.

FDA regulates your label and your product. That means the Supplement Facts panel, your ingredients, the claims printed on packaging, and whether any ingredient counts as new. FTC regulates your advertising, every objective claim you make in ads, on your site, on Amazon, or in an influencer brief. Both expect the same thing in spirit: claims that are truthful, not misleading, and backed by evidence you hold before you publish them.

The structure under FDA is the Dietary Supplement Health and Education Act, or DSHEA. It lets you make structure/function claims (how an ingredient supports normal body function) without pre-approval, as long as you follow the rules below. What you cannot do is claim your product treats, cures or prevents a disease. That line is where brands get warning letters.

What each piece costs in 2026

Here is what founders actually want: the numbers. The table below is built from FDA and FTC guidance (for the fees, which are zero) and 2025 to 2026 pricing across supplement compliance consultants, labeling reviewers and clinical research vendors. Treat these as budgeting ranges, not quotes.

Three things to read out of that table:

• The government fee column is all zeros. FDA charges nothing to review labels against its rules, to receive a structure/function claim notification, or to receive an NDI notification. Every dollar you spend is service, lab or legal time.
• Label and claim review are cheap and recurring. Budget a few hundred to a couple thousand dollars per SKU. This is the baseline cost of carrying a product, and it repeats every time you reformulate or add a claim.
• FTC substantiation is the line that explodes. Existing science assembled into a file is manageable. A new randomized controlled trial is not: even a small one can easily exceed $150,000, with the full range running $50,000 to $250,000 or more, per supplement clinical research vendors.

DSHEA claims: the disclaimer and the 30-day clock

If you make a structure/function claim, two obligations attach, per FDA's structure/function claims page.

First, the disclaimer. Your label must carry, in boldface and linked to each claim, this exact text: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." Get this wrong, or omit it, and an otherwise legal claim becomes a labeling violation.

Second, the 30-day notification. You must notify FDA of the claim no later than 30 days after you first market the product with it, and include the claim text. The filing itself is free. The cost is the consultant or attorney time to draft compliant claim language and keep a log of what you have filed. Budget roughly $500 to $3,000 per claim depending on how much wordsmithing it takes to stay on the structure/function side of the line.

FTC substantiation: where the real money is

This is the obligation that quietly sets your ceiling on marketing. Under Section 5 of the FTC Act and the FTC's Health Products Compliance Guidance, every objective claim in your advertising needs competent and reliable scientific evidence before you run it. The FTC defines that as objective tests, analyses or studies conducted by qualified people and generally accepted to yield reliable results.

In practice, for most efficacy claims, that means well-conducted human clinical trials, and the FTC's updated guidance leans hard toward randomized controlled trials for strong claims. So the cost of an FTC-defensible claim is not a filing fee. It is the science:

• If credible published science already supports your ingredient at your dose, your cost is an attorney or regulatory consultant assembling a substantiation file, roughly $1,500 to $7,500 per claim set.
• If you want to claim a benefit the existing literature does not cover, you are funding a study. That is the $50,000 to $250,000-plus line, and it is why aggressive claims should be a deliberate financial decision, not a marketing whim.

The cheapest FTC strategy is discipline: make claims your existing evidence already supports, and treat any claim that needs new science as a capital project with an ROI case.

NDI notifications: the launch-blocker for novel ingredients

If you formulate with a new dietary ingredient, one not sold in a US supplement before October 15, 1994 and not otherwise exempt, you owe FDA a premarket notification at least 75 days before you sell it, per FDA's NDI notification process. The notification is free to file. The dossier behind it (ingredient identity, history of use, toxicology and a safety conclusion) is not, and typically runs $25,000 to $150,000 or more depending on whether new safety testing is needed.

The financial takeaway: a novel ingredient is not just a sourcing decision, it is a regulatory capital outlay plus a 75-day delay to revenue. Most growing brands stick to well-established ingredients precisely to avoid this, and reserve NDI spend for a genuine differentiator.

What to do about it

Here is how I would run supplement compliance if it were my brand:

1. Treat compliance as a per-SKU and per-claim line, not a legal bill. Put a label-review and claim-review number into every product's margin build. Compliance scales with SKUs and claims, the same way COGS scales by vertical, where supplements run a healthy gross margin near 75% that compliance costs quietly chip at.
2. Get a label review before every print run. A $350 to $1,500 review is cheap insurance against reprinting thousands of units or eating a warning letter. Pay it on new and reformulated SKUs.
3. Write claims your existing evidence supports. Map each claim to the science you already hold. Reserve new clinical studies for one or two hero claims with a real ROI case, and put that spend through the same approval gate as any capex.
4. Build the 30-day notification habit. Any new structure/function claim triggers an FDA notification within 30 days. Keep a simple log so nothing slips past the deadline.
5. Make NDI a go or no-go gate, not a surprise. Before sourcing a novel ingredient, confirm whether it needs an NDI notification, then price in both the dossier cost and the 75-day delay.
6. Coordinate label and ad copy. FDA reads your label, FTC reads your ads, and your website is often both. Keep claim language consistent across packaging, site and Amazon so one review covers more ground. Fold the recurring cost into pricing the same way you would any supplement tax and overhead line, and price the product to absorb it from day one in how to price supplements.

Compliance also sits right next to your cost of goods. The same per-unit discipline that governs supplement cGMP cost and COGS should govern your compliance spend, and your R&D budget should account for it too, the way we treat CPG R&D as a percent of revenue. If you want help turning these ranges into a real per-SKU number inside your P&L, that is exactly the work our fractional CFO for supplements brands team does.

Methodology

Regulatory requirements, deadlines and the zero-fee structure come from FDA and FTC primary sources: FDA's structure/function claims page, the DSHEA disclaimer guidance, the NDI notification process, and the FTC Health Products Compliance Guidance. The Supplement Facts panel is governed by 21 CFR 101.36. Dollar ranges are 2025 to 2026 pricing observed across supplement labeling consultants, regulatory counsel and clinical research vendors; they are budgeting ranges, not quotes, and vary by SKU count, claim strength and ingredient. Margin context draws on Eightx's COGS by vertical data. Always confirm current requirements with FDA, FTC or qualified counsel before relying on them.

Frequently Asked Questions